开发、实施和评估Dexmedetomidine注入协议作为阿片类药物保留技术在脊柱手术
描述
背景:阿片类药物的基础治疗手术痛苦,尽管他们的负面影响包括慢性手术后的疼痛的发展。加强手术后恢复有助于改善病人的结果通过使用多通道止痛剂和限制阿片管理。Dexmedetomidine镇静剂,显著opioid-sparing功能。目的:这个质量改进项目旨在开发和实施的以证据为基础的协议,合并dexmedetomidine注入患者脊柱手术。数据收集分析结果是否与文献一致。方法:收集基线数据实现协议的前50个病人。教育简报关于麻醉的协议实现当时完成供应商在卡拉马祖麻醉学确保熟悉的协议和利益dexmedetomidine作为止痛剂。数据收集实现后对所有病人正确完整的协议以及任何dexmedetomidine病人正确的剂量。结果:只有11例全部收到了协议而另一个至少19收到正确的总剂量dexmedetomidine。所有的结果评估,没有达到统计学意义。 However, time to rescue analgesic (p = .835) as well as PACU discharge time (p = .50) was shortest in the full protocol group. Interestingly, average opioid administration in each area was lowest among the partial protocol group. Conclusion: This quality improvement project’s results did not align with the current evidence likely in part due to lack of provider adherence. This project did however show a possibility of a decreased time to rescue analgesic and PACU discharge times which could be a reflection of a more balanced anesthetic when a dexmedetomidine infusion is utilized.
主题
dexmedetomidine
阿片类药物的
脊柱外科手术
时代
多通道
阿片类药物的
脊柱外科手术
时代
多通道